An interventional study of Locally Available Food in Moderate Acute Malnutrition (MAM), sponsored by Epicentre. Completed at 1 site in Niger. Open to participants aged 6 Months to 23 Months. Per ClinicalTrials.gov, last updated 2026-04-07.
Sponsored by Epicentre · Not applicable, Interventional, and Supportive care
The study consisted of two phases. Phase 1 was a recipe development phase, which aimed to identify recipes that meet ≥80% of the recommended nutrient profile for Specially Formulated Foods (SFF) used in the standard management of MAM and made with locally available ingredients. In Phase 2, the recipes developed during Phase 1 were evaluated for acceptability among children 6 to \< 24 months of age with MAM during a randomized crossover feeding study with a 30-minute observed test dose and evaluation of at-home use.
331 studies on the registry are indexed under Cachexia; 75 are open to participants now.
This study's enrollment of 30 is below the median of 74 across 226 interventional studies indexed under Cachexia.
Browse Cachexia studies →Epicentre is the lead sponsor of 49 studies on the registry; 6 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
* 45g wheat, bran * 10g cowpea, uncooked * 39g sesame butter, tahini * 25g fish, dried fresh water * 3g leaf, drumstick, dried * 9g baobab, pulp, flour * 2g MNP, WFP 2022
Other: Locally Available Food
* 44g wheat, bran * 16g cowpea, uncooked * 38g fish, dried fresh water * 3g leaf, drumstick, dried * 9g baobab, pulp, flour * 20g oil, vegetable * 2g MNP, WFP 2022
Other: Locally Available Food
* 34g sesame butter, tahini * 16g okra, dried * 14g bean, african locust, fermented, dried * 46g fish, dried fresh water * 19g leaf, baobab, dried * 7g baobab, pulp, flour * 2g MNP, WFP 2022
Other: Locally Available Food
* 24g cowpea, uncooked * 4g groundnut, flour with fat * 90g fish, sardines in oil, canned * 24g leaf, drumstick, dried * 8g baobab, pulp, flour * 10g oil, vegetable * 20g beef, dried, boneless * 2g MNP, WFP 2022
Other: Locally Available Food
* 32g millet, finger * 7g cowpea, uncooked * 11g sesame butter, tahini * 10g groundnut paste * 20g groundnut, flour with fat * 8g fish, dried fresh water * 4g leaf, drumstick, dried * 16g leaf, baobab, dried * 8g baobab, pulp, flour * 4g oil, vegetable * 2g MNP, WFP 2022
Other: Locally Available Food
* 166g okra, dried * 8g fish, dried fresh water * 14g Leaf, drumstick, dried * 23g oil, groundnut * 2g MNP, WFP 2022
Other: Locally Available Food
Phase 1 of the present study developed supplementary food recipes using locally available, non-perishable ingredients. Market surveys identified 49 foods, reduced to 30 suitable items. Using linear programming in the Cost of the Diet software, 24 recipes meeting ≥80% of the nutrient profile for standard MAM treatment were generated, each including 2 g of micronutrient powder. A 2022 market survey in Maradi assessed prices and year-round availability; only six recipes met this requirement and were selected. A standardized method for at-home preparation of each recipe was developed.
Observed test dose acceptability
Consumption of ≥ 75% of the 50 g test dose within 30 minutes
Time frame: During 30 minutes of test dose administration
At-home observation acceptability
Consumption of ≥ 75% of the caregiver-prepared recipe within the 12-hour observation period
Time frame: 12 hours
Observed test dose consumption
Consumption (defined as grams of food provided at the start of the test dose minus grams of food left at the conclusion of the test dose)
Time frame: During 30 minutes of test dose administration
Observed test dose recipe organoleptic ratings
Taste, smell, odor, color, and overall as reported by the caregiver on a 5-point Likert scale (1 = "dislike a lot" and 5 = "like a lot").
Time frame: Following completion of the 30-minute test dose period
Observed test dose perceived child liking
Perceived child liking as reported by the caregiver on a 5-point Likert scale (1 = "dislike a lot" and 5 = "like a lot")
Time frame: Following completion of the 30-minute test dose period
At-home observation recipe organoleptic ratings
Taste, smell, odor, color, and overall as reported by the caregiver on a 5-point Likert scale (1 = "dislike a lot" and 5 = "like a lot")
Time frame: 12 hours (7AM - 7PM on at-home observation day)
At-home observation child willingness to eat the food
Voluntarily eaten, encouraged to consume, rejected
Time frame: 12 hours (7AM - 7PM on at-home observation day)
At-home observation caregiver willingness to use the recipe in the future
As reported on a 5-point Likert scale (1 = "not at all willing" and 5 = "extremely willing")
Time frame: 12 hours (7AM - 7PM on at-home observation day)
Plan to share: Undecided
No publications or documents are linked to this record.
Ran from Aug 2022 to primary completion in Nov 2022, 2 months.
Of 75 non-industry interventional studies with no phase under Cachexia, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 49. This study's 2 months is below that.
Counting every sponsor, half of 77 studies reached it within 19 months; a quarter within 12 and three quarters within 49.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Epicentre